Chikungunya natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
mNo edit summary
Line 5: Line 5:


==Overview==
==Overview==
Complications are rare and include [[uveitis]], [[retinitis]], [[myocarditis]], [[hepatitis]], [[nephritis]], [[bullous]] skin lesions, [[hemorrhage]], [[meningoencephalitis]], [[myelitis]], [[Guillain-Barré syndrome]], and [[cranial nerve palsies]].  Persons at risk for severe disease include [[neonates]] exposed [[intrapartum]], older adults (e.g., > 65 years), and persons with underlying medical conditions (e.g., [[hypertension]], [[diabetes]], or [[cardiovascular disease]]).
 
Complications are rare and include [[uveitis]], [[retinitis]], [[myocarditis]], [[hepatitis]], [[nephritis]], [[bullous]] skin lesions, [[hemorrhage]], [[meningoencephalitis]], [[myelitis]], [[Guillain-Barré syndrome]], and [[cranial nerve palsies]].  Persons at risk for severe disease include [[neonates]] exposed intrapartum, older adults (e.g., > 65 years), and persons with underlying medical conditions (e.g., [[hypertension]], [[diabetes]], or [[cardiovascular disease]]). Most patients recover uneventfully, but variable proportions of patients may have persistent [[arthralgias]] ([[joint pains]]) for months to years.


==Natural History==
==Natural History==
Most patients recover uneventfully, but variable proportions of patients may have persistent [[arthralgias]] ([[joint pains]]) for months to years.
 
In a 14-month prospective observational study among travelers from areas with outbreaks, nearly all confirmed cases had [[fever]], [[rash]], and [[arthritis]] within 10 days of the disease onset, and the majority had [[rheumatism]] persisting longer than 2 weeks, characterized by finger and toe [[polyarthritis]] with morning [[stiffness]], subacute [[tenosynovitis]] of wrists, hands, and ankles, or exacerbation of mechanic pain in previously injured joints and bones.<ref name="SimonParola2007">{{cite journal|last1=Simon|first1=Fabrice|last2=Parola|first2=Philippe|last3=Grandadam|first3=Marc|last4=Fourcade|first4=Sabrina|last5=Oliver|first5=Manuela|last6=Brouqui|first6=Philippe|last7=Hance|first7=Pierre|last8=Kraemer|first8=Philippe|last9=Mohamed|first9=Anzime Ali|last10=de Lamballerie|first10=Xavier|last11=Charrel|first11=R??mi|last12=Tolou|first12=Hugues|title=Chikungunya Infection|journal=Medicine|volume=86|issue=3|year=2007|pages=123–137|issn=0025-7974|doi=10.1097/MD/0b013e31806010a5}}</ref>


==Complications==
==Complications==
*Complications are rare and include [[uveitis]], [[retinitis]], [[myocarditis]], [[hepatitis]], [[nephritis]], [[bullous]] skin lesions, [[hemorrhage]], [[meningoencephalitis]], [[myelitis]], [[Guillain-Barré syndrome]], and [[cranial nerve palsies]].
 
*Some patients may experience relapse of [[rheumatologic symptoms]] (e.g., [[polyarthralgia]], [[polyarthritis]], [[tenosynovitis]]) in the months following acute illness.
* Complications are rare and include [[uveitis]], [[retinitis]], [[myocarditis]], [[hepatitis]], [[nephritis]], [[bullous]] skin lesions, [[hemorrhage]], [[meningoencephalitis]], [[myelitis]], [[Guillain-Barré syndrome]], and [[cranial nerve palsies]].
 
* Some patients may experience relapse of [[rheumatologic symptoms]] (e.g., [[polyarthralgia]], [[polyarthritis]], [[tenosynovitis]]) in the months following acute illness. It has been suggested that musculoskeletal complications are immune-mediated, and the presence of [[autoantibodies]] has been reported in infected patients with rheumatic symptoms.<ref name="Maek-a-nantawatSilachamroon2009">{{cite journal|last1=Maek-a-nantawat|first1=Wirach|last2=Silachamroon|first2=Udomsak|title=Presence of Autoimmune Antibody in Chikungunya Infection|journal=Case Reports in Medicine|volume=2009|year=2009|pages=1–4|issn=1687-9627|doi=10.1155/2009/840183}}</ref>
 
* Neurologic complications including [[encephalitis]], [[febrile seizure]]s, and [[encephalopathy|encephalopathies]] are common causes of hospitalization for pediatric patients with [[Chikungunya virus]] infection.<ref name="RobinRamful2008">{{cite journal|last1=Robin|first1=S.|last2=Ramful|first2=D.|last3=Le Seach|first3=F.|last4=Jaffar-Bandjee|first4=M.-C.|last5=Rigou|first5=G.|last6=Alessandri|first6=J.-L.|title=Neurologic Manifestations of Pediatric Chikungunya Infection|journal=Journal of Child Neurology|volume=23|issue=9|year=2008|pages=1028–1035|issn=0883-0738|doi=10.1177/0883073808314151}}</ref>


===Risk factors for Complications===
===Risk factors for Complications===
Persons at risk for severe disease include [[neonates]] exposed [[intrapartum]], older adults (e.g., > 65 years), and persons with underlying medical conditions (e.g., [[hypertension]], [[diabetes]], or [[cardiovascular disease]]).
 
Persons at risk for severe disease include [[neonates]] exposed intrapartum, older adults (e.g., > 65 years), and persons with underlying medical conditions (e.g., [[hypertension]], [[diabetes]], or [[cardiovascular disease]]).


==Prognosis==
==Prognosis==
Line 21: Line 28:


==References==
==References==
* [http://www.cdc.gov/Chikungunya/index.html CDC Chikungunya virus]


{{Reflist|2}}
{{Reflist|2}}
==External Links==
* [http://www.cdc.gov/Chikungunya/index.html CDC Chikungunya virus]


[[Category:Disease]]
[[Category:Disease]]
Line 30: Line 40:
[[Category:Togaviruses]]
[[Category:Togaviruses]]
[[Category:Tropical disease]]
[[Category:Tropical disease]]
[[Category:Needs content]]

Revision as of 22:43, 13 June 2014

Chikungunya Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Chikungunya from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Chikungunya natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chikungunya natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chikungunya natural history, complications and prognosis

CDC on Chikungunya natural history, complications and prognosis

Chikungunya natural history, complications and prognosis in the news

Blogs on Chikungunya natural history, complications and prognosis

Directions to Hospitals Treating Chikungunya

Risk calculators and risk factors for Chikungunya natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2], Alonso Alvarado, M.D. [3]

Overview

Complications are rare and include uveitis, retinitis, myocarditis, hepatitis, nephritis, bullous skin lesions, hemorrhage, meningoencephalitis, myelitis, Guillain-Barré syndrome, and cranial nerve palsies. Persons at risk for severe disease include neonates exposed intrapartum, older adults (e.g., > 65 years), and persons with underlying medical conditions (e.g., hypertension, diabetes, or cardiovascular disease). Most patients recover uneventfully, but variable proportions of patients may have persistent arthralgias (joint pains) for months to years.

Natural History

In a 14-month prospective observational study among travelers from areas with outbreaks, nearly all confirmed cases had fever, rash, and arthritis within 10 days of the disease onset, and the majority had rheumatism persisting longer than 2 weeks, characterized by finger and toe polyarthritis with morning stiffness, subacute tenosynovitis of wrists, hands, and ankles, or exacerbation of mechanic pain in previously injured joints and bones.[1]

Complications

Risk factors for Complications

Persons at risk for severe disease include neonates exposed intrapartum, older adults (e.g., > 65 years), and persons with underlying medical conditions (e.g., hypertension, diabetes, or cardiovascular disease).

Prognosis

Most patients recover uneventfully. Mortality is rare. Risk factors for death include older age.

References

  1. Simon, Fabrice; Parola, Philippe; Grandadam, Marc; Fourcade, Sabrina; Oliver, Manuela; Brouqui, Philippe; Hance, Pierre; Kraemer, Philippe; Mohamed, Anzime Ali; de Lamballerie, Xavier; Charrel, R??mi; Tolou, Hugues (2007). "Chikungunya Infection". Medicine. 86 (3): 123–137. doi:10.1097/MD/0b013e31806010a5. ISSN 0025-7974.
  2. Maek-a-nantawat, Wirach; Silachamroon, Udomsak (2009). "Presence of Autoimmune Antibody in Chikungunya Infection". Case Reports in Medicine. 2009: 1–4. doi:10.1155/2009/840183. ISSN 1687-9627.
  3. Robin, S.; Ramful, D.; Le Seach, F.; Jaffar-Bandjee, M.-C.; Rigou, G.; Alessandri, J.-L. (2008). "Neurologic Manifestations of Pediatric Chikungunya Infection". Journal of Child Neurology. 23 (9): 1028–1035. doi:10.1177/0883073808314151. ISSN 0883-0738.

External Links